Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam Tosylate for Long-Term Sedation in Mechanically Ventilated ICU Patients
NCT07880548Phase 3Not yet recruiting
- Sponsor
- Sun Yat-sen University
- Start
- Oct 2026
- Primary completion
- Jul 2028
- Countries
- 1
01
Overview
A Phase 3 trial of remimazolam in sedation, sponsored by Sun Yat-sen University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
sedation
Beyond the preview
Go deeper on NCT07880548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07880548.